MHRA to amend Human Medicines and Clinical Trials legislation to unleash drug innovation
The UK drugs agency is planning to help speed up production of innovative medicines, such as cell and gene therapy, through amending the 2004 Human Medicines and Clinical Trials legislation later this year.
The goal is to cut red tape and get medicines to patients more quickly, and to benefit innovators “by providing clear regulatory expectations and enabling easier product development”, said the Medicines and Healthcare products Regulatory Agency on 25 January.